Results 1 to 10 of about 694,898 (303)

Solid Cancers after Bone Marrow Transplantation

open access: yesNew England Journal of Medicine, 1997
Gérard Socie, Lois Travis
exaly   +2 more sources

Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report

open access: yesBMC Cancer, 2019
Following publication of the original article [1], the authors reported that the incorrect Fig. 2A was published in the article. The recovery times required to achieve a normal neutrophil count was omitted. The corrected Fig.
Mengqi Jin   +9 more
doaj   +1 more source

Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India

open access: yesThrombosis Journal, 2022
Background Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but devastating adverse event following adenoviral vector-based vaccinations for COVID-19, resulting in thrombosis, especially of the cerebral and splanchnic vasculature. Despite the
Christy V. John   +5 more
doaj   +1 more source

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

open access: yesBiology of Blood and Marrow Transplantation, 2008
We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease (GVHD) after outpatient nonmyeloablative conditioning and T cell-replete bone marrow transplantation ...
L. Luznik   +26 more
semanticscholar   +1 more source

Bone Marrow Transplantation

open access: yesSurgical Clinics of North America, 1986
The current status of bone marrow transplantation is reviewed. The diseases that are treatable with marrow transplantation, the basic transplant procedure, and the potential complications of marrow transplantation are discussed in detail. The future application of marrow transplantation to additional disease processes is considered.
C B, Thompson, E D, Thomas
openaire   +4 more sources

BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases

open access: yesMolecular Cytogenetics, 2023
Background BCR::ABL1-like acute lymphoblastic leukaemia (BCR::ABL1-like ALL) is characterized by inferior outcomes. Current efforts concentrate on the identification of molecular targets to improve the therapy results.
Anna Płotka   +10 more
doaj   +1 more source

An effective treatment in Erdheim Chester disease: vemurafenib: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Erdheim Chester disease (ECD) is a rare disease with multisystemic involvement in the group of non-langerhans cell histiocytosis. Although nearly 100 years have passed since its definition, the number of cases reported all over the world is ...
Ersin Bozan   +6 more
doaj   +1 more source

Young bone marrow transplantation preserves learning and memory in old mice

open access: yesCommunications Biology, 2019
Restoration of cognitive function in old mice by transfer of blood or plasma from young mice has been attributed to reduced C–C motif chemokine ligand 11 (CCL11) and β2-microglobulin, which are thought to suppress neurogenesis in the aging brain. However,
Melanie M. Das   +13 more
semanticscholar   +1 more source

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast

open access: yesMolecular Cytogenetics, 2017
Background Myelodysplastic syndromes (MDS) are clonal stem cell disorders exhibiting cytopenias, ineffective hematopoiesis and morphological dysplasia. Bone marrow cytogenetics, inspite of being incorporated as mandatory tool in diagnosis are done less ...
Nida Anwar   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy